Relaxin physiology in the female reproductive tract during pregnancy

Advances in Experimental Medicine and Biology

Volumn 612, Issue , 2007, Pages 34-48

  Parry, Laura J ^a   Vodstrcil, Lenka A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

G PROTEIN COUPLED RECEPTOR; RELAXIN;

APOPTOSIS; BIOCHEMISTRY; BIRTH; CELL PROLIFERATION; DECIDUALIZATION; ENDOMETRIUM; EXTRACELLULAR MATRIX; FEMALE GENITAL SYSTEM; HUMAN; NONHUMAN; PLACENTA DEVELOPMENT; PREGNANCY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; STROMA; UTERINE CERVIX; UTERINE CERVIX EPITHELIUM; UTERUS; UTERUS GROWTH; VAGINA; VASCULARIZATION; ANGIOGENESIS; ANIMAL; DYSTOCIA; EMBRYO MEMBRANE; FEMALE; METABOLISM; MOUSE; NIDATION; PHYSIOLOGY; PLACENTA; REPRODUCTION;

ANIMALS; CERVIX UTERI; DYSTOCIA; EMBRYO IMPLANTATION; ENDOMETRIUM; EXTRACELLULAR MATRIX; EXTRAEMBRYONIC MEMBRANES; FEMALE; HUMANS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PARTURITION; PLACENTA; PLACENTATION; PREGNANCY; RELAXIN; VAGINA;

EID: 38749094859     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-74672-2_4     Document Type: Review

References (100)

1. Hisaw FL. Experimental relaxation of the pubic ligament of the guinea pig. Proc Soc Exp Biol Med 1926; 23:661-663.
2. Sherwood OD. Relaxin's physiological roles and other diverse actions. Endocr Rev 2004; 25(2):205-234.
3. Guico-Lamm ML, Voss EWJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. II. Passive immunization with monoclonal antibodies throughout the second half of pregnancy disrupts birth in intact rats. Endocrinology 1988; 123(5):2479-2485.
4. Hwang JJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. III. Passive immunization with monoclonal antibodies throughout the second half of pregnancy reduces cervical growth and extensibility in intact rats. Endocrinology 1988; 123(5):2486-2490.
5. Kuenzi MJ, Sherwood OD. Monoclonal antibodies specific for rat relaxin. VII. Passive immunization with monoclonal antibodies throughout the second half of pregnancy prevents development of normal mammary nipples morphology and function in rats. Endocrinology 1992; 131(4):1841-1847.
6. Zhao L, Roche PJ, Gunnerson JM et al. Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 1999; 140(1):445-453.
7. Weiss G, Palejwala S, Tseng L et al. Synthesis and function of relaxin in human endometrium. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers, 2001:41-45.
8. Hayes ES. Biology of primate relaxin: a paracrine signal in early pregnancy? Reprod Biol Endocrinol 2004; 2:36.
9. Hsu SY, Nakabayashi K, Nishi S et al. Activation of orphan receptors by the hormone relaxin. Science 2002; 295:671-674.
10. Hsu SYT. New insights into the evolution of the relaxin-LGR signalling system. Trends Endocrin Met 2003; 14(7):303-309.
11. Scott DJ, Layfield S, Riesewijk A et al. Identification and characterization of the mouse and rat relaxin receptors as the novel orthologues of human leucine-rich repeat-containing G-protein-coupled receptor 7. Clin Exp Pharmacol Physiol 2004; 31(11):828-832.
12. Bathgate RA, Ivell R, Sanborn BM et al. International Union of Pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 2006; 58(1):7-31.
13. Dessauer CW, Nguyen BT. Relaxin stimulates multiple signaling pathways: activation of cAMP, PI3K and PKCzeta in THP-1 cells. Ann NY Acad Sci 2005; 1041:272-279.
14. Nguyen BT, Dessauer CW. Relaxin stimulates protein kinase C zeta translocation: requirement for cyclic adenosine 3′,5′-monophosphate production. Mol Endocrinol 2005; 19(4):1012-1023.
15. Kuenzi MJ, Connolly BA, Sherwood OD. Relaxin acts directly on rat mammary nipples to stimulate their growth. Endocrinology 1995; 136(7):2943-2947.
16. Min G, Sherwood OD. Identification of specific relaxin-binding cells in the cervix, mammary glands, nipples, small intestine and skin of pregnant pigs. Biol Reprod 1996; 55:1243-1252.
17. Mercado-Simmen RC, Bryant-Greenwood GD, Greenwood FC. Characterization of the binding of 125I-relaxin to rat uterus. J Biol Chem 1980; 225:3617-3623.
18. Mercado-Simmen RC, Bryant-Greenwood GD, Greenwood FC. Relaxin receptor in the rat myometrium: regulation by estrogen and relaxin. Endocrinology 1982; 110(1):220-226.
19. Tan YY, Wade JD, Tregear GW et al. Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment. Br J Pharmacol 1999; 127(1):91-98.
20. Hsu SY, Kudo M, Chen T et al. The three subfamilies of leucine-rich repeat-containing G protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signalling mechanism for LGR7. Mol Endocrinol 2000; 14(8):1257-1271.
21. Krajnc-Franken MAM, van Disseldorp JM, Koenders JE et al. Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 2004; 24(2):687-696.
22. Feng S, Bogatcheva NV, Kamat AA et al. Endocrine effects of relaxin overexpression in mice. Endocrinology 2006; 147(1):407-414.
23. Siebel AL, Gehring HM, Reytomas IGT et al. Inhibition of oxytocin receptor and estrogen receptor-α, but not relaxin receptors (LGR7), in the myometrium of late pregnant relaxin gene knockout mice. Endocrinology 2003; 144(10):4272-4275.
24. Siebel AL, Gehring HM, Vodstrcil L et al. Oxytocin and estrogen receptor expression in the myometrium of pregnant relaxin-deficient (Rlx-/-) mice. Ann NY Acad Sci 2005; 1041:104-109.
25. Kohsaka T, Min G, Lukas G et al. Identification of specific relaxin-binding cells in the human female. Biol Reprod 1998; 59:991-999.
26. Ivell R, Balvers M, Pohnke Y et al. Immunoexpression of the relaxin receptor LGR7 in breast and uterine tissues of humans and primates. Reprod Biol Endocrinol 2003; 1:114-126.
27. Luna JJ, Riesewijk A, Horcajadas JA et al. Gene expression pattern and immunoreactive protein localization of LGR7 receptor in human endometrium throughout the menstrual cycle. Mol Hum Reprod 2004; 10(2):85-90.
28. Bond CP, Parry LJ, Samuel CS et al. Increased expression of the relaxin receptor (LGR7) in human endometrium during the secretory phase of the menstrual cycle. J Clin Endocr Metab 2004; 89(7):3477-3485.
29. Mazella J, Tang M, Tseng L. Disparate effects of relaxin and TGF beta1: relaxin increases, but TGF beta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells. Hum Reprod 2004; 19(7):1513-1518.
30. Einspanier A, Muller D, Lubberstedt J et al. Characterization of relaxin binding in the uterus of the marmoset monkey. Mol Hum Reprod 2001; 7(10):963-970.
31. Lowndes K, Amano A, Yamamoto SY et al. The human relaxin receptor (LGR7): expression in the fetal membranes and placenta. Placenta 2006; 27(6-7):610-618.
32. Scott DJ, Layfield S, Yan Y et al. Characterization of novel splice variants of LGR7 and LGR8 reveals that receptor signaling is mediated by their unique low density lipoprotein class A modules. J Biol Chem 2006; 281(46):34942-34954.
33. Sherwood OD. Multiple physiological effects of relaxin during pregnancy. In: Bazer FW, ed. The Endocrinology of Pregnancy. Totowa, New Jersey: Human Press Inc.; 1998:431-460.
34. Sherwood OD, Zhao S. Effects of relaxin on the cervix and vagina in the rat. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Acadmic Publishers; 2001:53-58.
35. Parry LJ, McGuane JT, Gehring HM et al. Mechanisms of relaxin action in the reproductive tract: studies in the relaxin-deficient (Rlx-/-) mouse. Ann N Y Acad Sci 2005; 1041:91-103.
36. Downing SJ, Sherwood OD. The physiological role of relaxin in the pregnant rat. IV. The influence of relaxin on cervical collagen and glycosaminoglycans. Endocrinology 1986; 118(2):471-479.
37. O'Day MB, Winn RJ, Easter RA et al. Hormonal control of the cervix in pregnant gilts. II. Relaxin promotes changes in the physical properties of the cervix in ovariectomized hormone-treated pregnant gilts. Endocrinology 1989; 125(6):3004-3010.
38. O'Day-Bowman MB, Winn RJ, Dziuk PJ et al. Hormonal control of the cervix in pregnant gilts. III. Relaxins influence on cervical biochemical properties in ovariectomized hormone-treated pregnant gilts. Endocrinology 1991; 129(4):1967-1976.
39. Zhao L, Samuel CS, Tregear GW et al. Collagen studies in late pregnant relaxin null mice. Biol Reprod 2000; 63:697-703.
40. Mushayandebvu TI, Rajabi MR. Relaxin stimulates interstitial collagenase activity in cultured uterine cervical cells from nonpregnant and pregnant but not immature guinea pigs; estradiol-17 beta restores relaxin's effect in immature cervical cells. Biol Reprod 1995; 53(5):1030-1037.
41. Palejwala S, Stein DE, Weiss G et al. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology 2001; 142(8):3405-3413.
42. Hwang JJ, Macinga D, Rorke EA. Relaxin modulates human cervical stromal cell activity. J Clin Endocrinol Metab 1996; 81(9):3379-3384.
43. Lenhart JA, Ryan PL, Ohleth KM et al. Relaxin increases secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 during uterine and cervical growth and remodeling in the pig. Endocrinology 2001; 142(9):3941-3949.
44. Goldsmith LT, Weiss G, Palejwala S et al. Relaxin regulation of endometrial structure and function in the rhesus monkey. Proc Natl Acad Sci USA 2004; 101(13):4685-4689.
45. Mookerjee I, Unemori EN, Du XJ et al. Relaxin modulates fibroblast function, collagen production and matrix metalloproteinase-2 expression by cardiac fibroblasts. Ann N Y Acad Sci 2005; 1041:190-193.
46. Samuel CS. Relaxin: antifibrotic properties and effects in models of disease. Clin Med Res 2005; 3(4):241-249.
47. Silvertown JD, Walia JS, Summerlee AJ et al. Functional expression of mouse relaxin and mouse relaxin-3 in the lung from an Ebola virus glycoprotein-pseudotyped lentivirus via tracheal delivery. Endocrinology 2006; 147(8):3797-3808.
48. Jeyabalan A, Novak J, Danielson LA et al. Essential role for vascular gelatinase activity in relaxin-induced renal vasodilation, hyperfiltration and reduced myogenic reactivity of small arteries. Circulation Research 2003; 93:1249-1257.
49. Jeyabalan A, Kerchner LJ, Fisher MC et al. Matrix metalloproteinase-2 activity, protein, mRNA and tissue inhibitors in small arteries from pregnant and relaxin-treated nonpregnant rats. J Appl Physiol 2006; 100(6):1955-1963.
50. Lenhart JA, Ryan PL, Ohleth KM et al. Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig. Endocrinology 2002; 143(1):91-98.
51. Burger LL, Sherwood OD. Evidence that cellular proliferation contributes to relaxin-induced growth of both the vagina and the cervix in the pregnant rat. Endocrinology 1995; 136(11):4820-4826.
52. Ramos JG, Varayoud J, Bosquiazzo VL et al. Cellular turnover in the rat uterine cervix and its relationship to estrogen and progesterone receptor dynamics. Biol Reprod 2002; 67:735-742.
53. Lee HY, Zhao S, Fields PA et al. The extent to which relaxin promotes proliferation and inhibits apoptosis of cervical epithelial and stromal cells is greatest during late pregnancy in rats. Endocrinology 2005; 146(1):511-518.
54. Burger LL, Sherwood OD. Relaxin increases the accumulation of new epithelial and stromal cells in the rat cervix during the second half of pregnancy. Endocrinology 1998; 139(9):3984-3995.
55. Zhao S, Fields PA, Sherwood OD. Evidence that relaxin inhibits apoptosis in the cervix and the vagina during the second half of pregnancy in the rat. Endocrinology 2001; 142(6):2221-2229.
56. Zhao S, Kuenzi M, Sherwood O. Monoclonal antibodies specific for rat relaxin. IX. Evidence that endogenous relaxin promotes growth of the vagina during the second half of pregnancy in rats. Endocrinology 1996; 137(2):425-430.
57. Johnson MR, Abdalla H, Allman AC et al. Relaxin levels in ovum donation pregnancies. Fertil Steril 1991; 56(1):59-61.
58. Relaxin and related peptides. New York: New York Academy of Sciences; 2005.
59. Steinetz BG, Beach VL, Blye RP et al. Changes in the composition of the rat uterus following a single injection of relaxin. Endocrinology 1957; 61:287-292.
60. Brennan DM, Zarrow MX. Water and electrolyte content of the uterus of the intact and adrenalectomized rat treated with relaxin and various steroid hormones. Endocrinology 1959; 64:907-913.
61. Vasilenko P, Mead JP, Weidmann JE. Uterine growth-promoting effects of relaxin: a morphometric and histological analysis. Biol Reprod 1986; 35:987-995.
62. Pillai SB, Rockwell C, Sherwood OD et al. Relaxin stimulates uterine edema via activation of estrogen receptors: blockade of its effects using ICI 182, 780, a specific estrogen receptor antagonist. Endocrinology 1999; 140(5):2426-2429.
63. Hall JA, Cantley TC, Day BN et al. Uterotropic actions of relaxin in prepubertal gilts. Biol Reprod 1990; 42(5-6):769-774.
64. Bagnell CA, Zhang Q, Downey B et al. Sources and biological actions of relaxin in pigs. J Reprod Fertil 1993; 48:127-138.
65. Bagnell CA, Yan W, Wiley AA et al. Effects of relaxin on neonatal porcine uterine growth and development. Ann N Y Acad Sci 2005; 1041:248-255.
66. Ohleth KM, Lenhart JA, Ryan PL et al. Relaxin increases insulin-like growth factors (IGFs) and IGF-binding proteins of the pig uterus in vivo. Endocrinology 1997; 138(9):3652-3658.
67. Ohleth KM, Zhang Q, Lenhart JA et al. Trophic effects of relaxin on reproductive tissus: role of the IGF system. Steroids 1999; 64(9):634-639.
68. Lenhart JA, Ryan PL, Ohleth KM et al. Expression of connexin-26, -32 and -43 gap junction proteins in the porcine cervix and uterus during pregnancy and relaxin-induced growth. Biol Reprod 1999; 61:1452-1459.
69. Ryan PL, Baum DL, Lenhart JA et al. Expression of uterine and cervical epithelial cadherin during relaxin-induced growth in pigs. Reproduction 2001; 122(6):929-937.
70. Brody S, Wiqvist N. Ovarian hormones and uterine growth: effects of estradiol, progesterone and relaxin on cell growth and cell division in the rat uterus. Endocrinology 1961; 68:971-977.
71. Pillai SB, Jones JM, Koos RD. Treatment of rats with 17 beta-estradiol or relaxin rapidly inhibits uterine estrogen receptor beta1 and beta2 messenger ribonucleic acid levels. Biol Reprod 2002; 67:1919-1926.
72. Hall JM, McDonnell DP. The estrogen receptor beta-isoform (ERbeta) of the human estrogen receptor modulates ERalpha transcriptional activity and is a key regulator of the cellular response to estrogens and antiestrogens. Endocrinology 1999; 140:5566-5578.
73. Lindberg MK, Moverare S, Skrtic S et al. Estrogen receptor (ER)-beta reduces ERalpha-regulated gene transcription, supporting a "ying yang" relationship between ERalpha and ERbeta in mice. Mol Endocrinol 2003; 17:203-208.
74. Huang JR, Tseng L, Bischof P et al. Regulation of prolactin production by progestin, estrogen and relaxin in human endometrial stromal cells. Endocrinology 1987; 121(6):2011-2017.
75. Zhu HH, Huang JR, Mazella J et al. Differential effects of progestin and relaxin on the synthesis and secretion of immunoreactive prolactin in long term culture of human endometrial stromal cells. J Clin Endocrinol Metab 1990; 71(4):889-899.
76. Tseng L, Gao JG, Chen R et al. Effect of progestin, antiprogestin and relaxin on the accumulation of prolactin and insulin-like growth factor-binding protein-1 messenger ribonucleic acid in human endometrial stromal cells. Biol Reprod 1992; 47(3):441-450.
77. Dimitriadis E, Stoikos C, Baca M et al. Relaxin and prostaglandin E(2) regulate interleukin 11 during human endometrial stromal cell decidualization. J Clin Endocrinol Metab 2005; 90(6):3458-3465.
78. Tang M, Mazella J, Zhu HH et al. Ligand activated relaxin receptor increases the transcription of IGFBP-1 and prolactin in human decidual and endometrial stromal cells. Mol Hum Reprod 2005; 11(4):237-243.
79. Pohnke Y, Kempf R, Gellersen B. CCAAT/enhancer-binding proteins are mediators in the protein kinase A-dependent activation of the decidual prolactin promoter. J Biol Chem 1999; 274(35):24808-24818.
80. Millar LK, Reiny R, Yamamoto SY et al. Relaxin causes proliferation of human amniotic epithelium by stimulation of insulin-like growth factor-II. Am J Obstet Gynecol 2003; 188(1):234-241.
81. Jauniaux E, Johnson MR, Jurkovic D et al. The role of relaxin in the development of the uteroplacental circulation in early pregnancy. Obstet Gynecol 1994; 84(3):339-342.
82. Unemori EN, Erikson ME, Rocco SE et al. Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women. Hum Reprod 1999; 14(3):800-806.
83. Palejwala S, Tseng L, Wojtczuk A et al. Relaxin gene and protein expression and its regulation of procollagenase and vascular endothelial growth factor in human endometrial cells. Biol Reprod 2002; 66:1743-1748.
84. Koos RD, Kazi AA, Roberson MS, Jones JM. New insight into the transcriptional regulation of vascular endothelial growth factor expression in the endometrium by estrogen and relaxin. Ann N Y Acad Sci 2005; 1041:233-247.
85. Silvertown JD, Ng J, Sato T et al. H2 relaxin overexpression increases in vivo prostate xenograft tumor growth and angiogenesis. Int J Cancer 2006; 118(1):62-73.
86. Hisaw FL, Hisaw FL, Jr., Dawson AB. Effects of relaxin on the endothelium of endometrial blood vessels in monkeys (Macaca mulatta). Endocrinology 1967; 81(2):375-385.
87. Dallenbach-Hellweg G, Battista JV, Dallenbach FD. Immunohistological and histochemical localization of relaxin in the metrial gland of the pregnant rat. Am J Anat 1965; 117(3):433-450.
88. Einspanier A. Relaxin is an important factor for uterine differentiation and implantation in the marmoset monkey. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001:73-82.
89. Seibold JR, Korn JH, Simms R et al. Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 2000; 132(11):871-879.
90. Longo M, Jain V, Vedemikov YP et al. Effects of recombinant human relaxin on pregnant rat uterine artery and myometrium in vitro. Am J Obstet Gynecol 2003; 188(6):1468-1476.
91. Novak J. Relaxin increases uterine blood flow in concious nonpregnant rats and decreases myogenic reactivity in isolated uterine arteries. FASEB. 2002; 16:A824.
92. Min G, Hartzog MG, Jennings RL et al. Evidence that endogenous relaxin promotes growth of the vagina and uterus during pregnancy in gilts. Endocrinology 1997; 138(2):560-565.
93. Conrad KP, Parry LJ, Shroff SG et al. Evidence that relaxin is a vascular-derived, locally-acting relaxing and compliance factor. J Soc Gynecol Invest 2005; 12:Suppl: 688A.
94. Sakbun V, Ali SM, Greenwood FC et al. Human relaxin in the amnion, chorion, decidua parietalis, basal plate and placental trophoblast by immunocytochemistry and northern analysis. J Clin Endocrinol Metab 1990; 70(2):508-514.
95. Liu HC, Mele CA, Noyes N et al. Endometrial secretory proteins enhance early embryo development. J Assist Reprod Genet 1994; 11(4):217-224.
96. Heinonen S, Taipale P, Saarikoski S. Weights of placentae from small-for-gestational age infants revisited. Placenta 2001; 22:399-404.
97. Stewart DR, Addiego LA, Pascoe DR et al. Breed differences in circulating equine relaxin. Biol Reprod 1992; 46(4):648-652.
98. Ryan PL, Vaala W, Bagnell CA. Evidence that equine relaxin is a good indicator of placental insufficiency in the mare. Paper presented at: Proceedings 44th Annual Convention of American Association of Equine Practitioners, 1998.
99. Ryan P, Vaala W, Bennett-Wimbush K et al. Relaxin and placental dysfunction in the horse. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001:91-99.
100. Pillai SB, Sherwood OD, Koos RD. Relaxin up-regulates rat uterine vascular endothelial growth factor mRNA in vivo. In: Tregear GW, Ivell R, Bathgate RA, Wade JD, eds. Relaxin 2000. Dordrecht, The Netherlands: Kluwer Academic Publishers; 2001:109-113.